OXB Establishes Innovation Board to Drive Cell & Gene Therapy Advancements

The Manila Times

OXB (LSE: OXB), a leading Contract Development and Manufacturing Organisation (CDMO) specializing in cell and gene therapies, has announced the launch of its Innovation and Technology Excellence Board (ITEB). This strategic move underscores OXB's co ...Read more